Cargando…
Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU
INTRODUCTION: Hepatic dysfunction is a common finding in critically ill patients on the ICU and directly influences survival. Liver stiffness can be measured by the novel method of transient elastography (fibroscan) and is closely associated with hepatic fibrosis in patients with chronic liver disea...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388655/ https://www.ncbi.nlm.nih.gov/pubmed/22082207 http://dx.doi.org/10.1186/cc10543 |
_version_ | 1782237219915825152 |
---|---|
author | Koch, Alexander Horn, Andreas Dückers, Hanna Yagmur, Eray Sanson, Edouard Bruensing, Jan Buendgens, Lukas Voigt, Sebastian Trautwein, Christian Tacke, Frank |
author_facet | Koch, Alexander Horn, Andreas Dückers, Hanna Yagmur, Eray Sanson, Edouard Bruensing, Jan Buendgens, Lukas Voigt, Sebastian Trautwein, Christian Tacke, Frank |
author_sort | Koch, Alexander |
collection | PubMed |
description | INTRODUCTION: Hepatic dysfunction is a common finding in critically ill patients on the ICU and directly influences survival. Liver stiffness can be measured by the novel method of transient elastography (fibroscan) and is closely associated with hepatic fibrosis in patients with chronic liver disease, but also is increased in patients with acute hepatitis, acute liver failure and cholestasis. We investigated liver stiffness as a potentially useful tool for early detection of patients with hepatic deterioration and risk stratification with respect to short- and long-term mortality. METHODS: We prospectively evaluated 108 consecutive critically ill patients at our medical intensive care unit (ICU) with subsequent longitudinal liver stiffness measurements (admission, Day 3, Day 7 and weekly thereafter) during the course of ICU treatment. Outcome was followed after discharge (median observation time 237 days). RESULTS: Liver stiffness could be reliably measured in 71% of ICU patients at admission (65% at Day 3, 63% at Day 7). Critically ill patients (n = 108) had significantly increased liver stiffness compared to sex- and age-matched standard care patients (n = 25). ICU patients with decompensated cirrhosis showed highest liver stiffness, whereas other critical diseases (for example, sepsis) and comorbidities (for example, diabetes, obesity) did not impact stiffness values. At admission to the ICU, liver stiffness is closely related to hepatic damage (liver synthesis, cholestasis, fibrosis markers). During the course of ICU treatment, fluid overload (renal failure, volume therapy) and increased central venous pressure (mechanical ventilation, heart failure) were major factors determining liver stiffness. Liver stiffness values > 18 kilopascal (kPa) at ICU admission were associated with increased ICU and long-term mortality, even in non-cirrhotic patients. CONCLUSIONS: Considering that liver stiffness cannot be validly measured in about 30% of ICU patients, transient elastography performed at ICU admission might be a useful tool to early identify liver dysfunction and predict mortality in critically ill patients at a medical ICU. |
format | Online Article Text |
id | pubmed-3388655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33886552012-07-04 Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU Koch, Alexander Horn, Andreas Dückers, Hanna Yagmur, Eray Sanson, Edouard Bruensing, Jan Buendgens, Lukas Voigt, Sebastian Trautwein, Christian Tacke, Frank Crit Care Research INTRODUCTION: Hepatic dysfunction is a common finding in critically ill patients on the ICU and directly influences survival. Liver stiffness can be measured by the novel method of transient elastography (fibroscan) and is closely associated with hepatic fibrosis in patients with chronic liver disease, but also is increased in patients with acute hepatitis, acute liver failure and cholestasis. We investigated liver stiffness as a potentially useful tool for early detection of patients with hepatic deterioration and risk stratification with respect to short- and long-term mortality. METHODS: We prospectively evaluated 108 consecutive critically ill patients at our medical intensive care unit (ICU) with subsequent longitudinal liver stiffness measurements (admission, Day 3, Day 7 and weekly thereafter) during the course of ICU treatment. Outcome was followed after discharge (median observation time 237 days). RESULTS: Liver stiffness could be reliably measured in 71% of ICU patients at admission (65% at Day 3, 63% at Day 7). Critically ill patients (n = 108) had significantly increased liver stiffness compared to sex- and age-matched standard care patients (n = 25). ICU patients with decompensated cirrhosis showed highest liver stiffness, whereas other critical diseases (for example, sepsis) and comorbidities (for example, diabetes, obesity) did not impact stiffness values. At admission to the ICU, liver stiffness is closely related to hepatic damage (liver synthesis, cholestasis, fibrosis markers). During the course of ICU treatment, fluid overload (renal failure, volume therapy) and increased central venous pressure (mechanical ventilation, heart failure) were major factors determining liver stiffness. Liver stiffness values > 18 kilopascal (kPa) at ICU admission were associated with increased ICU and long-term mortality, even in non-cirrhotic patients. CONCLUSIONS: Considering that liver stiffness cannot be validly measured in about 30% of ICU patients, transient elastography performed at ICU admission might be a useful tool to early identify liver dysfunction and predict mortality in critically ill patients at a medical ICU. BioMed Central 2011 2011-11-14 /pmc/articles/PMC3388655/ /pubmed/22082207 http://dx.doi.org/10.1186/cc10543 Text en Copyright ©2011 Koch et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Koch, Alexander Horn, Andreas Dückers, Hanna Yagmur, Eray Sanson, Edouard Bruensing, Jan Buendgens, Lukas Voigt, Sebastian Trautwein, Christian Tacke, Frank Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU |
title | Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU |
title_full | Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU |
title_fullStr | Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU |
title_full_unstemmed | Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU |
title_short | Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU |
title_sort | increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical icu |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388655/ https://www.ncbi.nlm.nih.gov/pubmed/22082207 http://dx.doi.org/10.1186/cc10543 |
work_keys_str_mv | AT kochalexander increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu AT hornandreas increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu AT duckershanna increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu AT yagmureray increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu AT sansonedouard increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu AT bruensingjan increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu AT buendgenslukas increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu AT voigtsebastian increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu AT trautweinchristian increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu AT tackefrank increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu |